EASL Congress 2026

Richmond Pharmacology is pleased to join the EASL Congress 2026 in Barcelona, Spain, on 27–30 May 2026.

As one of the world’s leading hepatology meetings, the EASL Congress brings together clinicians, researchers, industry experts, and global stakeholders to explore the latest advances in liver disease research, diagnostics, therapeutics, and clinical care.

Representing Richmond Pharmacology:

• Dr Jörg Taubel, Chief Executive Officer

‍

Our Focus at the Congress

• Emerging therapies and clinical strategies for liver disease

• Translation of hepatology research into early‑phase clinical development

• Biomarker‑driven approaches to trial design and patient selection

• Evolving regulatory pathways for hepatology therapeutics

• Collaboration across academia, industry, and global liver health communities

Connect With Us

If you are attending the EASL Congress 2026 and would like to explore collaboration or development opportunities:

📧 fasteranswers@richmondpharmacology.com

‍

Find out more here: EASL Congress 2026 - EASL-The Home of Hepatology.

‍